Patent · US Active

Galactose—pronged polysaccharides in a formulation for antifibrotic therapies

US8236780B2 · kind B2 · utility

15Cited by

21References

3Claims

0Family size

Assignee

GALECTIN THERAPEUTICS, INC. · US

Inventors

David Platt · Newton, US
Eliezer Zomer · Newton, US
Anatole Klyosov · Newton, US

Key dates

Filing date	May 16, 2007
Grant date	Aug 7, 2012
Priority date	—
Expiry date	Oct 18, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC08B37/006
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods and compositions for reducing fibrosis are provided, wherein an admixture of at least a galactose-pronged polymer and a pharmaceutically acceptable carrier is obtained and administered, wherein the administration of a sufficient amount of the admixture is measured by a quantitative change in a fibrosis tissue marker.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.